Spatial, temporal, and functional aspects of macrophages during "The good, the bad, and the ugly" phases of inflammation

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Harris, Robert A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adoptive; Immunotherapy; M1 M2 macrophages; Macrophage activation; Microenvironment; Phenotype

Indexed keywords

CD86 ANTIGEN; CELL SURFACE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL COMPARTMENTALIZATION; CHRONIC INFLAMMATION; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MICROENVIRONMENT; PROTEIN EXPRESSION; REMYELINIZATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UPREGULATION;

EID: 84919767830     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00612     Document Type: Article

References (32)

1. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164:6166-73. doi: 10.4049/jimmunol.164.12.6166
2. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8:958-69. doi:10.1038/nri2448
3. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 41:14-20. doi:10.1016/j.immuni.2014.06.008
4. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity (2014) 40:274-88. doi:10.1016/j.immuni.2014.01.006
5. Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 10:35. doi:10.1186/1742-2094-10-35
6. Franklin RJM. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci (2002) 3:705-14. doi:10.1038/nrn917
7. Schouppe E, De Baetselier P, Van Ginderachter JA, Sarukhan A. Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. Oncoimmunology (2012) 1:1135-45. doi:10.4161/onci.21566
8. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res (2006) 66:605-12. doi:10.1158/0008-5472.CAN-05-4005
9. Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Van den Bossche J, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res (2010) 70:5728-39. doi:10.1158/0008-5472.CAN-09-4672
10. Laoui D, Van Overmeire E, Di Conza G, Aldeni C, Keirsse J, Morias Y, et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. Cancer Res (2014) 74:24-30. doi:10.1158/0008-5472.CAN-13-1196
11. Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, McLoed AG, et al. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol (2011) 187:5703-11. doi:10.4049/jimmunol.1100558
12. Kuang D-M, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood (2007) 110:587-95. doi:10.1182/blood-2007-01-068031
13. Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol (2011) 12:43. doi:10.1186/1471-2172-12-43
14. Stöger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, Biessen EA, et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis (2012) 225:461-8. doi:10.1016/j.atherosclerosis.2012.09.013
15. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, Malkinson AM. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol (2010) 88:159-68. doi:10.1189/jlb.0609378
16. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 330:841-5. doi:10.1126/science.1194637
17. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med (2012) 209:1167-81. doi:10.1084/jem.20120340
18. Barth MW, Hendrzak JA, MelnicoffMJ, Morahan PS. Review of the macrophage disappearance reaction. J Leukoc Biol (1995) 57:361-7.
19. Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J Leukoc Biol (2004) 76:1118-24. doi:10.1189/jlb.0704385
20. Vogel DY, Glim JE, Stavenuiter AW, Breur M, Heijnen P, Amor S, et al. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology (2014) 219:695-703. doi:10.1016/j.imbio.2014.05.002
21. Verreck FA, de Boer T, Langenberg DM, van der OttenhoffTH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol (2006) 79:285-93. doi:10.1189/jlb.0105015
22. Parsa R, Andresen P, Gillett A, Mia S, Zhang XM, Mayans S, et al. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes (2012) 61:2881-92. doi:10.2337/db11-1635
23. Lee J, French B, Morgan T, French SW. The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2. Exp Mol Pathol (2014) 96:118-25. doi:10.1016/j.yexmp.2013.09.004
24. Morland B, Kaplan G. Macrophage activation in vivo and in vitro. Exp Cell Res (1977) 108:279-88. doi:10.1016/S0014-4827(77)80035-9
25. McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci U S A (2013) 110:17253-8. doi:10.1073/pnas.1308887110
26. Zhang XM, Lund H, Mia S, Parsa R, Harris RA. Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia (2014) 62:804-17. doi:10.1002/glia.22643
27. Mukherjee S, Rodriguez-Canales J, Hanson J, Emmert-Buck MR, Tangrea MA, Prieto DA, et al. Proteomic analysis of frozen tissue samples using laser capture microdissection. Methods Mol Biol (2013) 1002:71-83. doi:10.1007/978-1-62703-360-2_6
28. Bonnet A, Bevilacqua C, Benne F, Bodin L, Cotinot C, Liaubet L, et al. Transcriptome profiling of sheep granulosa cells and oocytes during early follicular development obtained by laser capture microdissection. BMC Genomics (2011) 12:417. doi:10.1186/1471-2164-12-417
29. Mia S, Warnecke A, Zhang XM, Malmström V, Harris RA. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-ß yields a dominant immunosuppressive phenotype. Scand J Immunol (2014) 79:305-14. doi:10.1111/sji.12162
30. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med (2009) 6(7):e1000113. doi:10.1371/journal.pmed.1000113
31. Yin Y, Huang X, Lynn KD, Thorpe PE. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res (2013) 1:256-68. doi:10.1158/2326-6066.CIR-13-0073
32. Mills CD, Shearer J, Evans R, Caldwell MD. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol (1992) 149:2709-14.